HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Etter, J.-F. Articles by Stapleton, J. A Search for Related Content PubMed PubMed Citation Articles by Etter, J.-F. Articles by Stapleton, J. A Related Collections Smoking Environmental tobacco smoke

Nicotine replacement therapy for long-term smoking cessation: a meta-analysis

¹ Institute of Social and Preventive Medicine, University of Geneva, Geneva, Switzerland
² Institute of Psychiatry-King’s College, London, UK

Correspondence to:
Dr Jean-Francois Etter
University of Geneva, CMU, 1 rue Michel-Servet, CH-1211 Geneve 4, Switzerland; Jean-Francois.Etter{at}imsp.unige.ch

ABSTRACT
Objective: To assess if the effect of a single treatment episode with nicotine replacement therapy (NRT) enhances smoking cessation over many years.

Data sources: Meta-analysis of all randomised controlled trials of NRT with final follow-up more than one year after the start of treatment. Twelve eligible trials were identified, all placebo-controlled, having final follow-ups ranging from 2–8 years. All had earlier follow-ups at 12 months. They comprised 2408 active and 2384 placebo treatment participants.

Data synthesis: The odds ratio (OR) in favour of NRT at final follow-up was 1.99 (95% confidence interval (CI) 1.50 to 2.64). There was no evidence that the effect varied according to length of final follow-up (ß = 0.92, p = 0.28) or duration of initial NRT treatment (ß = 0.99, p > 0.5). The overall relapse rate between the 12 months and final follow-up was 30.0% (95% CI 23.5% to 37.5%). This rate did not differ between NRT and control groups (OR 1.11, 95% CI 0.78 to 1.59), or length of initial NRT treatment. There was also no evidence that it varied according to length of final follow up. Due to relapse, the overall efficacy of NRT treatment in terms of additional ex-smokers declined from 10.7% over and above placebo (6.6% to 14.8%) after one year to 7.2% (3.8% to 11.3%) at an average of 4.3 years follow up.

Conclusions: The relative efficacy of a single course of NRT remains constant over many years. The majority of relapse after 12 months occurs within the first or second year and is not detectable thereafter, suggesting that NRT has a permanent effect on smoking cessation. However, initial relapse after one year has the effect of diminishing the number of ex-smokers that can be ultimately attributed to NRT. Results after only 6–12 months of follow-up, as used in existing reviews and treatment guidelines, will overestimate the lifetime benefit and cost-efficacy of NRT by about 30%. Because the long-term benefit of NRT is modest, tobacco dependence treatment might be better viewed as a chronic disorder, requiring repeated episodes of treatment.

Keywords: tobacco dependence; nicotine replacement therapy; long-term follow-up; meta-analysis

This article has been cited by other articles:

				M. B. Steinberg, A. C. Schmelzer, D. L. Richardson, and J. Foulds The Case for Treating Tobacco Dependence as a Chronic Disease Ann Intern Med, April 1, 2008; 148(7): 554 - 556. [Abstract] [Full Text] [PDF]

				K. H. Ginzel, G. S. Maritz, D. F. Marks, M. Neuberger, Jim. R. Pauly, J. R. Polito, R. Schulte-Hermann, and T. A. Slotkin Critical Review: Nicotine for the Fetus, the Infant and the Adolescent? J Health Psychol, March 1, 2007; 12(2): 215 - 224. [Abstract] [PDF]